Lv41
440 积分 2022-06-24 加入
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
5小时前
待确认
Lung Cancer An Evidence-Based Approach to Multidisciplinary Management
3个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
3个月前
已关闭
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
4个月前
已完结
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
5个月前
已完结
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
5个月前
已完结
Surgery or Surveillance for Esophageal Squamous Cell Carcinoma With Clinical Complete Response After Neoadjuvant Chemoradiotherapy
5个月前
已完结
Perspectives on the pharmacological management of esophageal cancer: where are we now and where do we need to go
5个月前
已完结
食管癌围术期免疫治疗进展
5个月前
已完结
Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis
5个月前
已完结
皖公网安备34019202002308
